Dr. Iwamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Independence Way
Princeton, NJ 08540Phone+1 609-720-5379Fax+1 908-504-7348
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1997 - 2001
- NYU Grossman School of MedicineResidency, Internal Medicine, 1995 - 1997
- Emory University School of MedicineClass of 1995
Certifications & Licensure
- NJ State Medical License 2002 - 2025
Publications & Presentations
PubMed
- Intracellular islatravir-triphosphate half-life supports extended dosing intervals.Xiaowei Zang, Wendy Ankrom, Walter K Kraft, Ryan Vargo, S Aubrey Stoch
Antimicrobial Agents and Chemotherapy. 2024-09-04 - 1 citationsSingle- and Multiple-Dose Pharmacokinetics of Gefapixant (MK-7264), a P2X3 Receptor Antagonist, in Healthy Adults.Jesse C Nussbaum, Azher Hussain, Peter Butera, Anthony P Ford, Michael M Kitt
Journal of Clinical Pharmacology. 2024-08-01 - 3 citationsAssessment of pharmacokinetics, safety, and tolerability following twice-daily administration of molnupiravir for 10 days in healthy participants.Marian Iwamoto, Kelly E Duncan, Prachi K Wickremasingha, Tian Zhao, Maria V Liberti
Clinical and Translational Science. 2023-10-01
Journal Articles
- Clinical Evaluation of MK‐2640: An Insulin Analog with Glucose‐Responsive PropertiesMarian Iwamoto, MD, Clinical Pharmacology & Therapeutics
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: